Cardio Diagnostics Holdings, Inc. (NasdaqCM: CDIO)
Health Care · Biotechnology · US
$1.69
-9.63% today · -62.4% 1Y
Cardio Diagnostics Holdings, Inc. (NasdaqCM: CDIO) operates in the Biotechnology industry within the Health Care sector. The company is valued at $5.00M and employs 15 people.
Over the last twelve months the share price has lost 62.4%, trading between 0.97 and 7.91.
Tweenvest scores Cardio Diagnostics Holdings, Inc. across four factors: quality 37/100, value 38/100. Its strongest factor is value.
CDIO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.00M
- Revenue (TTM)
- $14.45K
- P/E
- —
- EPS
- -2.76
- Dividend yield
- —
- Beta (5Y)
- 2.24
- 52-week high
- $7.91
- 52-week low
- $0.97
- Avg volume (3M)
- —
- Shares outstanding
- 2.96M
- Employees
- 15
- Next earnings
- —
About Cardio Diagnostics Holdings, Inc.
Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017.
- ISIN
- US14159C2026
- Founded
- 2017
- Listed since
- Jan 14, 2022
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Alpha Compute CorpNasdaqCM: ALP | $5.27M | $3.40 | -14.36% |
| Marvel Biosciences Corp.TSXV: MRVL | $5.22M | CA$0.10 | -13.04% |
| AIM ImmunoTech Inc.NYSEAM: AIM | $5.12M | $0.17 | -6.61% |
| Plant Advanced Technologies SAENXTPA: ALPAT | $5.01M | €3.98 | +1.02% |
| genXone S.A.WSE: GX1 | $4.90M | zł5.76 | -2.37% |
| Creative Medical Technology Holdings, Inc.NasdaqCM: CELZ | $4.89M | $0.74 | -11.63% |
| bioAffinity Technologies, Inc.NasdaqCM: BIAF | $4.79M | $3.73 | -21.06% |
| Stem Cells Spin S.A.WSE: SCS | $4.68M | zł0.44 | -10.20% |
Figures last refreshed Oct 18, 2026.